CMMB
NASDAQ
IL
Chemomab Therapeutics Ltd. - American Depositary Shares
$1.56
▼ $-0.03
(-1.89%)
Vol 48K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$10.1M
ROE
-89.9%
D/E
0.00
Beta
0.54
52W
$2–$10
Wall Street Consensus
8 analysts · Apr 20263
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 20.0%
Next Report
May 13, 2026
EPS Estimate: $-0.16
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.16 | — | — |
| Dec 2025 | $-0.32 | $-0.24 | +$0.08 |
| Mar 2025 | $-0.04 | $-0.56 | $-0.52 |
| Dec 2024 | $-0.32 | $-0.64 | $-0.32 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -$3.5M | -$3.0M | -$3.3M | -$2.1M | -$1.7M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -95.3% | -106.7% | -94.7% | -94.7% | -95.3% | -89.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 7.42 | 5.33 | 7.42 | 7.42 | 7.42 | 10.49 |
Key Ratios
ROA (TTM)
-75.7%
P/B
2.5
EPS (TTM)
$-0.07
CF/Share
$-47.12
52W High
$9.84
52W Low
$1.71
$1.71
52-Week Range
$9.84
Financial Health
Cash
$7.0M
Total Debt
$0
As of Sep 30, 2025
How does CMMB compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
CMMB valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
2.5
▲
2%
above
peers
(2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
CMMB profitability vs Biotechnology peers
ROE
-89.9%
▼
34%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-75.7%
▼
62%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
CMMB financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
10.5
▲
136%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.5
▼
44%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
CMMB fundamentals radar
CMMB
Peer median
Industry
CMMB profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
CMMB vs peers: key metrics
Top Holders
Top 5: 4.98%Citadel Advisors Llc
1.69%
$152K
Adar1 Capital Management, L…
1.30%
$117K
Ikarian Capital, LLC
0.84%
$76K
Kestra Private Wealth Servi…
0.84%
$75K
Xtx Topco Ltd
0.31%
$28K
As of Dec 31, 2025
Latest News
No related news yet